Market Cap 617.85M
Revenue (ttm) 42.07M
Net Income (ttm) -130.30M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -309.72%
Debt to Equity Ratio 0.00
Volume 1,066,278
Avg Vol 3,225,076
Day's Range N/A - N/A
Shares Out 108.39M
Stochastic %K 81%
Beta 1.63
Analysts Strong Sell
Price Target $10.43

Company Profile

Tango Therapeutics, Inc., a precision oncology company, focuses on the discovery and development of drugs in defined patient populations with unmet medical need. The company develops methylthioadenosine -cooperative protein arginine methyltransferase 5 (PRMT5) inhibitors, including TNG462, which is in Phase 1/2 clinical trial for treating pancreatic and lung cancer; and TNG456, a brain-penetrant PRMT5 inhibitor for the treatment of glioblastoma. It is developing TNG260, a co-repressor of repress...

Industry: Biotechnology
Sector: Healthcare
Phone: 857 320 4900
Address:
201 Brookline Avenue, Suite 901, Boston, United States
LabPsycho
LabPsycho Jul. 2 at 6:28 PM
$TNGX How to explain TNGX $600M market cap, more than 300% increase in ~ a month, few pumpers on this board, and an impressive chart? See below is one hypothesis, but any one else have any other wild speculations?
0 · Reply
prismmarketview
prismmarketview Jun. 30 at 2:24 PM
$TNGX https://prismmarketview.com/new-tango-trial-targets-toughest-cancers-with-precision-combo-therapy/
0 · Reply
LabPsycho
LabPsycho Jun. 27 at 11:05 PM
$TNGX Shown below is my Molecular Dynamic Simulation of TNG462 bound to PRMT5·MTA . Molecular ensemble built in part from X-ray crystal structure of TNG908 & TNG462 bound to PRMT5·MTA PDB ID: 8VEY 9N3Q. References: J. Med. Chem. 2025, 68, 5, 5097–5119. Molecular ensemble built in part using VMD, Colab, Openmm, Alpha Fold, Python, SwissParam and LabPsycho’s Artificial Artificial IntelligenceTM (A.^2 I.) This simulation highlights the dynamic interaction between the rotating N-methylpiperidine of TNG462 with the acid of Glu320 via a salt bridge. If you like this kind of stuff go (what's the purpose!?) check out my recent simulation of C4 Therapeutics $CCCC molecular glue. Methodology described in more detail in the YouTube video posted on the CCCC board that was also used there.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 27 at 11:15 AM
$TNGX Tango Therapeutics Doses First Patient In Phase 1/2 Combo Trial With Revolution Medicines' RAS Inhibitors For MTAP-Deleted Cancers
0 · Reply
_www_larval_com_
_www_larval_com_ Jun. 25 at 7:53 PM
$SAFX -7%[26%] $NXTT -3%[9%] $XFOR -3%[-10%] $PRTG 3%[19%] $TNGX -3%[-9%] most notable movement into the final minutes of trading.
0 · Reply
Dmlcdm
Dmlcdm Jun. 24 at 2:23 PM
0 · Reply
Rush4040
Rush4040 Jun. 24 at 1:53 PM
$TNGX !???!???? 2,000 shares at 4.90$
1 · Reply
LabPsycho
LabPsycho Jun. 22 at 2:22 PM
$TNGX Shown below is my Molecular Dynamic Simulation of TNG908 bound to PRMT5·MTA . Molecular ensemble built in part from X-ray crystal structure of TNG908 bound to PRMT5·MTA PDB ID: 8VEY. References: Journal of Medicinal Chemistry 2025 68 (5), 5097-5119 DOI: 10.1021/acs.jmedchem.4c03067 Molecular ensemble built in part using VMD, Colab, Openmm, Alpha Fold, Python, SwissParam and LabPsycho’s Artificial Artificial IntelligenceTM (A2.I.) If you like this kind of stuff go (what's the purpose!?) check out my recent simulation of C4 Therapeutics $CCCC molecular glue. Methodology described in more detail in the YouTube video posted on the CCCC board that was also used here.
0 · Reply
MGeronimo
MGeronimo Jun. 20 at 10:13 PM
$TNGX 1.10 to 5.16 bam
0 · Reply
BioTechHealthX
BioTechHealthX Jun. 19 at 6:27 AM
$TNGX Despite a Q1 earnings miss, analyst confidence in Tango’s cancer pipeline remains strong. Could this be the perfect entry for biotech bulls? https://biotechhealthx.com/biotech-news/analysts-say-tango-tngx-is-worth-10-43-heres-why-it-might-go-even-higher/
0 · Reply
Latest News on TNGX
Tango Therapeutics: Chance For A Short Squeeze

Jan 23, 2025, 5:44 AM EST - 5 months ago

Tango Therapeutics: Chance For A Short Squeeze


Tango Therapeutics to Participate in Upcoming Investor Conferences

Aug 28, 2024, 7:00 AM EDT - 11 months ago

Tango Therapeutics to Participate in Upcoming Investor Conferences


Tango Therapeutics to stop development of cancer therapy

May 23, 2024, 7:19 AM EDT - 1 year ago

Tango Therapeutics to stop development of cancer therapy


Circling Bank On Tango Therapeutics

Oct 23, 2023, 6:26 PM EDT - 1 year ago

Circling Bank On Tango Therapeutics


Tango Therapeutics Announces Updates to Its Board of Directors

Aug 29, 2023, 5:08 PM EDT - 2 years ago

Tango Therapeutics Announces Updates to Its Board of Directors


Tango Therapeutics: Partial Phase 1 Data Has Not Helped

Jul 26, 2023, 7:29 PM EDT - 2 years ago

Tango Therapeutics: Partial Phase 1 Data Has Not Helped


Tango Therapeutics: Behind The Recent Momentum

Nov 14, 2022, 4:11 PM EST - 2 years ago

Tango Therapeutics: Behind The Recent Momentum


LabPsycho
LabPsycho Jul. 2 at 6:28 PM
$TNGX How to explain TNGX $600M market cap, more than 300% increase in ~ a month, few pumpers on this board, and an impressive chart? See below is one hypothesis, but any one else have any other wild speculations?
0 · Reply
prismmarketview
prismmarketview Jun. 30 at 2:24 PM
$TNGX https://prismmarketview.com/new-tango-trial-targets-toughest-cancers-with-precision-combo-therapy/
0 · Reply
LabPsycho
LabPsycho Jun. 27 at 11:05 PM
$TNGX Shown below is my Molecular Dynamic Simulation of TNG462 bound to PRMT5·MTA . Molecular ensemble built in part from X-ray crystal structure of TNG908 & TNG462 bound to PRMT5·MTA PDB ID: 8VEY 9N3Q. References: J. Med. Chem. 2025, 68, 5, 5097–5119. Molecular ensemble built in part using VMD, Colab, Openmm, Alpha Fold, Python, SwissParam and LabPsycho’s Artificial Artificial IntelligenceTM (A.^2 I.) This simulation highlights the dynamic interaction between the rotating N-methylpiperidine of TNG462 with the acid of Glu320 via a salt bridge. If you like this kind of stuff go (what's the purpose!?) check out my recent simulation of C4 Therapeutics $CCCC molecular glue. Methodology described in more detail in the YouTube video posted on the CCCC board that was also used there.
0 · Reply
Thestocktraderhubzee
Thestocktraderhubzee Jun. 27 at 11:15 AM
$TNGX Tango Therapeutics Doses First Patient In Phase 1/2 Combo Trial With Revolution Medicines' RAS Inhibitors For MTAP-Deleted Cancers
0 · Reply
_www_larval_com_
_www_larval_com_ Jun. 25 at 7:53 PM
$SAFX -7%[26%] $NXTT -3%[9%] $XFOR -3%[-10%] $PRTG 3%[19%] $TNGX -3%[-9%] most notable movement into the final minutes of trading.
0 · Reply
Dmlcdm
Dmlcdm Jun. 24 at 2:23 PM
0 · Reply
Rush4040
Rush4040 Jun. 24 at 1:53 PM
$TNGX !???!???? 2,000 shares at 4.90$
1 · Reply
LabPsycho
LabPsycho Jun. 22 at 2:22 PM
$TNGX Shown below is my Molecular Dynamic Simulation of TNG908 bound to PRMT5·MTA . Molecular ensemble built in part from X-ray crystal structure of TNG908 bound to PRMT5·MTA PDB ID: 8VEY. References: Journal of Medicinal Chemistry 2025 68 (5), 5097-5119 DOI: 10.1021/acs.jmedchem.4c03067 Molecular ensemble built in part using VMD, Colab, Openmm, Alpha Fold, Python, SwissParam and LabPsycho’s Artificial Artificial IntelligenceTM (A2.I.) If you like this kind of stuff go (what's the purpose!?) check out my recent simulation of C4 Therapeutics $CCCC molecular glue. Methodology described in more detail in the YouTube video posted on the CCCC board that was also used here.
0 · Reply
MGeronimo
MGeronimo Jun. 20 at 10:13 PM
$TNGX 1.10 to 5.16 bam
0 · Reply
BioTechHealthX
BioTechHealthX Jun. 19 at 6:27 AM
$TNGX Despite a Q1 earnings miss, analyst confidence in Tango’s cancer pipeline remains strong. Could this be the perfect entry for biotech bulls? https://biotechhealthx.com/biotech-news/analysts-say-tango-tngx-is-worth-10-43-heres-why-it-might-go-even-higher/
0 · Reply
SadyK189
SadyK189 Jun. 18 at 12:24 AM
$TNGX Price 4.35. My post was "Looking good on daily chart. 3.1 - 3.4 is acting as key support zone. Next key level to test is 4.85 - 5.15. Currently at 4.35" It hit our desired zone, went till 5.06 today
0 · Reply
Stmkr
Stmkr Jun. 13 at 3:56 PM
$TNGX This one will get acquired soon
0 · Reply
LabPsycho
LabPsycho Jun. 12 at 6:05 PM
$TNGX IMO, Longs should expect this mystery move to push TNGX above $5 soon. (btw I started typing this when it was $4.76. Then a big spike up, then the second day after that spike down taking out the stop loss orders. Good luck
1 · Reply
Chauncy_Peppertooth
Chauncy_Peppertooth Jun. 11 at 2:51 PM
0 · Reply
Stonkman88
Stonkman88 Jun. 11 at 1:24 PM
$WINT with some fresh news out today as well $IXHL $KBSX $TNGX
0 · Reply
SadyK189
SadyK189 Jun. 9 at 12:13 AM
Top Stocks to watch next week 2 / 2: $SGMT $TNGX $HYPD $SXTC $ZONE SGMT is trending nicely on daily chart. Key support at 4.5 - 4.85. Next key level to test is 6.4 - 6.9. Currently at 5.54 TNGX: Looking good on daily chart. 3.1 - 3.4 is acting as key support zone. Next key level to test is 4.85 - 5.15. Currently at 4.35 SXTC: Good close of daily candle. 1.4 - 1.55 is key support zone. Next key level to test is 2.55 - 2.75. Currently at $2. ZONE: Alerted earlier for 4 - 4.40. It's at 4.29. Still looking good on daily chart. key support at 3.3 - 3.65 now. Next key level to test is 4.9 - 5.35 EYEN: Looking good on daily chart. Key support at 3.2 - 3.5. It can test 5.4 - 5.75 zone again.
0 · Reply
Avocado_smash
Avocado_smash Jun. 7 at 5:50 PM
$TNGX Monday: 4.20 - 5.13+ Open, trade and closed below that range, pullback might start.
0 · Reply
biolover
biolover Jun. 7 at 5:31 PM
$TNGX these technical guys here are annoying and boring. Let us wait and see what Weber will mention at GS. She can’t keep her mouth shut ( although I like her )
0 · Reply
PolackStock
PolackStock Jun. 6 at 10:07 PM
$TNGX are they issuing stock? https://www.tipranks.com/news/company-announcements/tango-therapeutics-approves-key-proposals-at-annual-meeting
0 · Reply
LabPsycho
LabPsycho Jun. 6 at 5:42 PM
$CADL Predicted the drip down from $9 to 4.5 in April, predicted the rebound occurring now last month and predicted there would not be any share buying by Dr. T. I'd like to say I know what he was or wasnt going to do before he did but I am guessing he knew all along he would not buy - and so did I. Yet not a single poster here can acknowledge that - instead they bash with nonsense name calling comments. Looks like LabPsycho’s Artificial Artificial Intelligence (A.^2 I.) ™ is now getting close to 90% accuraty. (recent examples the past ~ month - $XLO down, CADL, $HOWL $TNGX and $CCCC up for example). I keep telling myself its all just a fluke...nothing to do with hundreds of hours of entering parameters, novel algorithms and simulations on Google's GPU supercomputer.
1 · Reply
_www_larval_com_
_www_larval_com_ Jun. 6 at 4:52 PM
$TNGX just reversed -6% lower to 17% (~6Mv) a few minutes ago, 06/20 options, follow for more volatility.
0 · Reply